Clearance Summary
INJECTRITE-C15 AND INJECTRITE-C30 received FDA 510(k) clearance under submission number K002127, sponsored by Sterling Medivations, Inc.. The device was reviewed via the Abbreviated premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 2000-12-29.
- Submission: K002127
- Applicant / Sponsor: Sterling Medivations, Inc.
- Clearance pathway: Abbreviated
- Review panel: General Hospital
- Device class: Class II
- Regulation citation: 21 CFR 880.5860
- Decision date: 2000-12-29
Classification & Regulation
This clearance is catalogued under FDA product code FMF and 21 CFR 880.5860, within the General Hospital review panel as a Class II device.